a Sanofi company, joins the global multiple sclerosis (MS) community
today in recognition of the seventh annual World MS Day, an initiative
created by the Multiple Sclerosis International Federation (MSIF) to
raise awareness of this devastating disease.
a Sanofi company, announced today that data on its relapsing multiple
sclerosis treatments, Aubagio® (teriflunomide) and
Lemtrada® (alemtuzumab), will be featured during the
2015 annual meeting of the Consortium of Multiple Sclerosis Centers
a Sanofi company, announced today that selected artwork from Expression
of Hope III will be featured through a travelling exhibit and online
gallery. Expression of Hope is a global disease awareness program
featuring works of art created by the community of people...
a Sanofi company, today announced that it has received the 2015 Industry
Innovation Award from the National Organization for Rare
Disorders (NORD) in recognition of Cerdelga® (eliglustat)
capsules. Genzyme was selected for the company’s work in bringing an...